VIRIOM, INC. enters TRAWS PHARMA, INC. with 1.65M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/3/2024ACC: 0000929638-24-001356
1.65M
Baseline shares
100% direct
1.65M
Direct ownership
1 position
48.01M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.65M
Total
1.65M direct1.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.65M | Direct |
| Total | 1.65M | 1.65M direct |
Derivative Holdings1
Series C Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
48.01M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
48.01M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series C Preferred Stock Direct | Common Stock | — | — | 48.01M | N/A | |
| Total | 48.01M | 0.00 | ||||